This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Heavy Menstrual Bleeding
and you are
between 18 and 51
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This study compares two treatments for the management of heavy menstrual bleeding, ulipristal acetate (UPA) and tranexamic acid (TEA), on health-related quality of life. Half of the participants will receive UPA and a placebo, and the other half will receive TEA and a placebo.

Provided treatments

  • Drug: UPA
  • Drug: TEA
  • Drug: Placebo (for UPA)
  • Drug: Placebo (for TEA)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03027973. The sponsor of the trial is University of Saskatchewan and it is looking for 60 volunteers for the current phase.
Official trial title:
Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding: A Pilot Randomized Control Trial